Quartz Atlas AI™ for Drug Discovery
Deloitte’s AI solution to accelerate medicinal breakthroughs, powered by NVIDIA
Generative AI can reduce the time and cost it takes to develop new pharmaceuticals. Deloitte Atlas AI, powered by NVIDIA, harnesses the power of generative AI to accelerate drug discovery by rapidly generating 3D biomolecular structures and predicting drug-to-protein binding. Atlas AI for drug discovery enhances efficiency throughout the drug discovery process with data-driven insights from gene to function.
Atlas AI™ powered by NVIDIA BioNeMo
Experience accelerated drug discovery with Deloitte's Atlas AI, powered by NVIDIA. Atlas AI enhances efficiency, offering data-driven insights from gene to function.
Harmonizing data and the scientific process to bridge the gap
We work with clients to create custom data paradigms, harmonizing fragmented multi-modal data for AI adoption, thus enabling our scientific solutions.
Our team operates at the convergence of diverse disciplines, including science, engineering, data, AI, business, consulting, and advisory, and we take each of them into deep consideration when approaching clients and scientific solutions.
Related content
Opens in new window
Deloitte and NVIDIA Alliance
Solving tomorrow’s challenges by accelerating AI innovation. Together, Deloitte and NVIDIA can help you seize opportunities only enabled through an accelerated AI platform. Our alliance allows us to help organizations access market-leading accelerated computing power and create deep learning models that can deliver new capabilities, value, and a competitive advantage.
Christine Ahn
